Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Fidaxomicin

SKU: orb1223774

Description

Fidaxomicin(OPT-80; PAR-101) is a new class of narrow spectrum macrocyclic antibiotic drug, selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria.Bacterial Infection Approved(In Vitro):Fidaxomicin selectively eradicates pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that make up the normal, healthy intestinal flora.Fidaxomicin is not inhibitory to commonly cultured bowel commensals (MIC90 >1024 μg/mL).(In Vivo):Fidaxomicin (0-5 mg/kg, Orally, once a day for 5 days) completely prevents the lethality of the animals and prevents the occurrence of relapses in a hamster model for pseudomembranous colitis.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number873857-62-6
MW1058.039
Purity>98% (HPLC)
FormulaC52H74Cl2O18
SMILESO=C(O[C@@H]1[C@@H](C)O[C@@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@H]3[C@@H](O)[C@@H](O)[C@H](OC(C(C)C)=O)C(C)(C)O3)/C(C)=C/C(C)=C/C[C@@H]([C@H](O)C)OC2=O)[C@@H](OC)[C@H]1O)C4=C(O)C(Cl)=C(O)C(Cl)=C4CC
TargetAntibacterial
SolubilityDMSO: ≥ 33 mg/mL

Bioactivity

In Vivo
Fidaxomicin (0-5 mg/kg, Orally, once a day for 5 days) completely prevents the lethality of the animals and prevents the occurrence of relapses in a hamster model for pseudomembranous colitis. Animal model: Male Golden Syrian hamsters (80-100 g, Hamster model for pseudomembranous colitis). Dosage: 0.2, 1, and 5 mg/kg. Administration: Orally, once a day for 5 days, beginning 8 h after infection. Result: Completely prevented the lethality of the animals. Completely prevented the development of antibiotic-induced C. difficile colitis in hamsters at doses as low as 0.2 mg/kg.
In Vitro
Fidaxomicin selectively eradicates pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that make up the normal, healthy intestinal flora. Fidaxomicin is not inhibitory to commonly cultured bowel commensals (MIC90 >1024 μg/mL).

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

OPT-80 | PAR-101

Similar Products

  • Fidaxomicin [orb1300992]

    99.82% (May vary between batches)

    873857-62-6

    1058.04

    C52H74Cl2O18

    25 mg, 10 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Protocol Information

Filter by Applications

Filter by Species

Wei Lin, Kalyan Das, David Degen, Abhishek Mazumder, Diego Duchi, Dongye Wang, Yon W. Ebright, Richard Y. Ebright, Elena Sineva, Matthew Gigliotti, Aashish Srivastava, Sukhendu Mandal, Yi Jiang, Yu Liu, Ruiheng Yin, Zhening Zhang, Edward T. Eng, Dennis Thomas, Stefano Donadio, Haibo Zhang, Changsheng Zhang, Achillefs N. Kapanidis, Richard H. Ebright Structural basis of transcription inhibition by fidaxomicin (lipiarmycin A3) Molecular Cell, 70, 60 (2018)

Applications

Activity Assay, In vitro

Reactivity

Bacteria

Available Sizes

Select a size below

500 mg
5 mg
$ 70.00
10 mg
$ 80.00
25 mg
$ 100.00
50 mg
$ 130.00
100 mg
$ 210.00
200 mg
$ 300.00